President Donald Trump announced that he had reached a deal with AstraZeneca (AZN) to cut consumer prices on some of the company’s drugs, in the second major deal between the White House and a pharmaceutical company seeking to reduce healthcare costs for Americans, Bloomberg’s Rachel Cohrs Zhang, Madison Muller, and Ashleigh Furlong report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca Stock (AZN) Flat despite Incoming Trump Pricing Deal, Virginia Plant Construction
- Trump Weekly: Generics to be excluded from pharma tariff plan
- AstraZeneca up 1% to $85.55 after MSNBC report on Trump pact
- Trump to announce price deal with AstraZeneca, MSNBC reports
- AstraZeneca’s New Trial Targets Sepsis-Related Kidney Injury